SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mihai Moldovan, Susana Alvarez, Mette R. Rosberg, Christian Krarup, Persistent alterations in active and passive electrical membrane properties of regenerated nerve fibers of man and mice, European Journal of Neuroscience, 2016, 43, 3
  2. 2
    Bardia Nourbakhsh, Emmanuelle Waubant, Multiple Sclerosis, 2016,

    CrossRef

  3. 3
    Diogo Trigo, Kenneth J. Smith, Axonal morphological changes following impulse activity in mouse peripheral nerve in vivo: the return pathway for sodium ions, The Journal of Physiology, 2015, 593, 4
  4. 4
    Gabriele C. DeLuca, Richard L. Yates, Harry Beale, Sarah A. Morrow, Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights, Brain Pathology, 2015, 25, 1
  5. 5
    Antonino Uncini, Satoshi Kuwabara, Nodopathies of the peripheral nerve: an emerging concept, Journal of Neurology, Neurosurgery & Psychiatry, 2015, 86, 11, 1186

    CrossRef

  6. 6
    Tsen-Hsuan Lin, Joong Hee Kim, Carlos Perez-Torres, Chia-Wen Chiang, Kathryn Trinkaus, Anne H. Cross, Sheng-Kwei Song, Axonal transport rate decreased at the onset of optic neuritis in EAE mice, NeuroImage, 2014, 100, 244

    CrossRef

  7. 7
    Manuel A. Friese, Benjamin Schattling, Lars Fugger, Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis, Nature Reviews Neurology, 2014, 10, 4, 225

    CrossRef

  8. 8
    Alireza Minagar, Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2014, 6, 4, 1

    CrossRef

  9. 9
    Natalia Palacios, Kathryn C Fitzgerald, Jaime E Hart, Marc G Weisskopf, Michael A Schwarzschild, Alberto Ascherio, Francine Laden, Particulate matter and risk of parkinson disease in a large prospective study of women, Environmental Health, 2014, 13, 1, 80

    CrossRef

  10. 10
    Andrew P. Robinson, Christopher T. Harp, Avertano Noronha, Stephen D. Miller, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  11. 11
    Alexandra Kutzelnigg, Hans Lassmann, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  12. 12
    Gerson Criste, Bruce Trapp, Ranjan Dutta, Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  13. 13
    Shadi Asadollahi, Mohammad Fakhri, Kamran Heidari, Ali Zandieh, Reza Vafaee, Behnam Mansouri, Cigarette smoking and associated risk of multiple sclerosis in the Iranian population, Journal of Clinical Neuroscience, 2013, 20, 12, 1747

    CrossRef

  14. 14
    Colin Martyn, Jun Li, Fig4 deficiency: A newly emerged lysosomal storage disorder?, Progress in Neurobiology, 2013, 101-102, 35

    CrossRef

  15. 15
    A. Créange, J.-P. Lefaucheur, M.-O. Balleyguier, F. Galactéros, Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements, Neurophysiologie Clinique/Clinical Neurophysiology, 2013, 43, 5-6, 303

    CrossRef

  16. 16
    R.E. Raftopoulos, R. Kapoor, Neuroprotection for acute optic neuritis—Can it work?, Multiple Sclerosis and Related Disorders, 2013, 2, 4, 307

    CrossRef

  17. You have free access to this content17
    D. Garcia-Gonzalez, V. Murcia-Belmonte, D. Clemente, F. De Castro, Olfactory System and Demyelination, The Anatomical Record, 2013, 296, 9
  18. 18
    Susana Alvarez, Mihai Moldovan, Christian Krarup, Prolonged high frequency electrical stimulation is lethal to motor axons of mice heterozygously deficient for the myelin protein P0 gene, Experimental Neurology, 2013, 247, 552

    CrossRef

  19. 19
    Jun Li, Brett Parker, Colin Martyn, Chandramohan Natarajan, Jiasong Guo, The PMP22 Gene and Its Related Diseases, Molecular Neurobiology, 2013, 47, 2, 673

    CrossRef

  20. 20
    Patricia Monasterio-Schrader, Julia Patzig, Wiebke Möbius, Benoit Barrette, Tadzio L. Wagner, Kathrin Kusch, Julia M. Edgar, Peter J. Brophy, Hauke B. Werner, Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2, Glia, 2013, 61, 11
  21. 21
    Kurien Koshy, Douglas W. Zochodne, Peripheral Nerve Disorders, 2013,

    CrossRef

  22. 22
    Reem F. Bunyan, Junger Tang, Brian Weinshenker, Acute Demyelinating Disorders: Emergencies and Management, Neurologic Clinics, 2012, 30, 1, 285

    CrossRef

  23. 23
    Cullen O’Gorman, Robyn Lucas, Bruce Taylor, Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms, International Journal of Molecular Sciences, 2012, 13, 12, 11718

    CrossRef

  24. 24
    Catharina G. Faber, Janneke G. J. Hoeijmakers, Hye-Sook Ahn, Xiaoyang Cheng, Chongyang Han, Jin-Sung Choi, Mark Estacion, Giuseppe Lauria, Els K. Vanhoutte, Monique M. Gerrits, Sulayman Dib-Hajj, Joost P. H. Drenth, Stephen G. Waxman, Ingemar S. J. Merkies, Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy, Annals of Neurology, 2012, 71, 1
  25. 25
    T. Hayton, J. Furby, K. J. Smith, D. R. Altmann, R. Brenner, J. Chataway, K. Hunter, D. J. Tozer, D. H. Miller, R. Kapoor, Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine, Journal of Neurology, 2012, 259, 3, 505

    CrossRef

  26. 26
    Felipe A. Court, Michael P. Coleman, Mitochondria as a central sensor for axonal degenerative stimuli, Trends in Neurosciences, 2012, 35, 6, 364

    CrossRef

  27. 27
    Graham R. Campbell, Nobuhiko Ohno, Doug M. Turnbull, Don J. Mahad, Mitochondrial changes within axons in multiple sclerosis, Current Opinion in Neurology, 2012, 25, 3, 221

    CrossRef

  28. 28
    David Baker, Gareth Pryce, Samuel J. Jackson, Chris Bolton, Gavin Giovannoni, The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis, Multiple Sclerosis and Related Disorders, 2012, 1, 2, 64

    CrossRef

  29. 29
    Ivana Nikić, Doron Merkler, Catherine Sorbara, Mary Brinkoetter, Mario Kreutzfeldt, Florence M Bareyre, Wolfgang Brück, Derron Bishop, Thomas Misgeld, Martin Kerschensteiner, A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis, Nature Medicine, 2011, 17, 4, 495

    CrossRef

  30. 30
    Andrew P. D. Henderson, Daniel R. Altmann, S. Anand Trip, Katherine A. Miszkiel, Patricio G. Schlottmann, Steve J. Jones, David F. Garway-Heath, Gordon T. Plant, David H. Miller, Early factors associated with axonal loss after optic neuritis, Annals of Neurology, 2011, 70, 6
  31. 31
    Beatriz Moreno, John-Paul Jukes, Nuria Vergara-Irigaray, Oihana Errea, Pablo Villoslada, V. Hugh Perry, Tracey A. Newman, Systemic inflammation induces axon injury during brain inflammation, Annals of Neurology, 2011, 70, 6
  32. 32
    Richard Reynolds, Federico Roncaroli, Richard Nicholas, Bishan Radotra, Djordje Gveric, Owain Howell, The neuropathological basis of clinical progression in multiple sclerosis, Acta Neuropathologica, 2011, 122, 2, 155

    CrossRef

  33. 33
    A. P. D. Henderson, D. R. Altmann, A. S. Trip, C. Kallis, S. J. Jones, P. G. Schlottmann, D. F. Garway-Heath, G. T. Plant, D. H. Miller, A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials, Brain, 2010, 133, 9, 2592

    CrossRef

  34. 34
    E. García-Martín, V. Pueyo, J. Fernández, C. Almárcegui, I. Dolz, J. Martín, J.R. Ara, F.M. Honrubia, Atrofia de la capa de fibras nerviosas de la retina en pacientes con esclerosis múltiple. Estudio prospectivo con dos años de seguimiento, Archivos de la Sociedad Española de Oftalmología, 2010, 85, 5, 179

    CrossRef

  35. 35
    E. García-Martín, V. Pueyo, J. Fernández, C. Almárcegui, I. Dolz, J. Martín, J.R. Ara, F.M. Honrubia, Atrophy of the retinal nerve fibre layer in multiple sclerosis patients. Prospective study with two years follow-up, Archivos de la Sociedad Española de Oftalmología (English Edition), 2010, 85, 5, 179

    CrossRef

  36. 36
    Hans Lassmann, Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models, Experimental Neurology, 2010, 225, 1, 2

    CrossRef

  37. 37
    M. Inglese, G. Madelin, N. Oesingmann, J. S. Babb, W. Wu, B. Stoeckel, J. Herbert, G. Johnson, Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla, Brain, 2010, 133, 3, 847

    CrossRef

  38. 38
    C. Almarcegui, I. Dolz, V. Pueyo, E. Garcia, F.J. Fernandez, J. Martin, J.R. Ara, F. Honrubia, Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients, Neurophysiologie Clinique/Clinical Neurophysiology, 2010, 40, 3, 129

    CrossRef

  39. 39
    E. García-Martín, V. Pueyo, J. Fernández, J. Martín, J.R. Ara, C. Almarcegui, I. Dolz, Effect of treatment in loss of retinal nerve fiber layer in multiple sclerosis patients, Archivos de la Sociedad Española de Oftalmología (English Edition), 2010, 85, 6, 209

    CrossRef

  40. 40
    Dimitrios Papadopoulos, Jon Rundle, Ryan Patel, Ian Marshall, Jennifer Stretton, Rachel Eaton, Jill C. Richardson, Maria I. Gonzalez, Karen L. Philpott, Richard Reynolds, FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses, Journal of Neuroscience Research, 2010, 88, 2
  41. 41
    J. L. Jones, J. M. Anderson, C.-L. Phuah, E. J. Fox, K. Selmaj, D. Margolin, S. L. Lake, J. Palmer, S. J. Thompson, A. Wilkins, D. J. Webber, D. A. Compston, A. J. Coles, Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity, Brain, 2010, 133, 8, 2232

    CrossRef

  42. 42
    Klaus G. Petry, Bruno Brochet, Vincent Dousset, Jean Rodolphe Vignes, Claudine Boiziau, Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies, Journal of Neural Transmission, 2010, 117, 8, 907

    CrossRef

  43. 43
    Rossen Donev, Johannes Thome, Inflammation: good or bad for ADHD?, ADHD Attention Deficit and Hyperactivity Disorders, 2010, 2, 4, 257

    CrossRef

  44. 44
    E. García-Martín, V. Pueyo, J. Fernández, J. Martín, J.R. Ara, C. Almarcegui, I. Dolz, Influencia del tratamiento en la pérdida de fibras nerviosas de la retina en pacientes con esclerosis múltiple, Archivos de la Sociedad Española de Oftalmología, 2010, 85, 6, 209

    CrossRef

  45. 45
    David P. Stirling, Peter K. Stys, Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation, Trends in Molecular Medicine, 2010, 16, 4, 160

    CrossRef

  46. 46
    Alastair Wilkins, Yoichi Kondo, Jonathan Song, Shujun Liu, Alastair Compston, Joel A. Black, Stephen G. Waxman, Ian D. Duncan, Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination, Journal of Neuropathology & Experimental Neurology, 2010, 69, 12, 1256

    CrossRef

  47. 47
    K. M. Myhr, S. I. Mellgren, Corticosteroids in the treatment of multiple sclerosis, Acta Neurologica Scandinavica, 2009, 120,
  48. 48
    Vanessa Hogan, Kathryn White, Julia Edgar, Alison McGill, Saadia Karim, Mark McLaughlin, Ian Griffiths, Doug Turnbull, Philip Nichols, Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model, Journal of Neuroscience Research, 2009, 87, 2
  49. 49
    D. J. Mahad, I. Ziabreva, G. Campbell, N. Lax, K. White, P. S. Hanson, H. Lassmann, D. M. Turnbull, Mitochondrial changes within axons in multiple sclerosis, Brain, 2009, 132, 5, 1161

    CrossRef

  50. 50
    Fotini Pittas, Anne-Louise Ponsonby, Ingrid A. F. Mei, Bruce V. Taylor, Leigh Blizzard, Patricia Groom, Obioha C. Ukoumunne, Terry Dwyer, Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis, Journal of Neurology, 2009, 256, 4, 577

    CrossRef

  51. You have free access to this content51
    Dimitrios Papadopoulos, Sumayya Dukes, Ryan Patel, Richard Nicholas, Abhilash Vora, Richard Reynolds, Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis, Brain Pathology, 2009, 19, 2
  52. 52
    Bruce D Trapp, Peter K Stys, Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis, The Lancet Neurology, 2009, 8, 3, 280

    CrossRef

  53. 53
    Susana Alvarez, Mihai Moldovan, Christian Krarup, Acute energy restriction triggers Wallerian degeneration in mouse, Experimental Neurology, 2008, 212, 1, 166

    CrossRef

  54. 54
    Elizabeth Gray, Taya Louise Thomas, Samar Betmouni, Neil Scolding, Seth Love, Elevated myeloperoxidase activity in white matter in multiple sclerosis, Neuroscience Letters, 2008, 444, 2, 195

    CrossRef

  55. 55
    Tamara Glaser, Tanja Schmandt, Oliver Brüstle, Generation and potential biomedical applications of embryonic stem cell-derived glial precursors, Journal of the Neurological Sciences, 2008, 265, 1-2, 47

    CrossRef

  56. 56
    Elliot M. Frohman, Todd Eagar, Nancy Monson, Olaf Stuve, Nitin Karandikar, Immunologic Mechanisms of Multiple Sclerosis, Neuroimaging Clinics of North America, 2008, 18, 4, 577

    CrossRef

  57. 57
    G. Comi, Is it clinically relevant to repair focal multiple sclerosis lesions?, Journal of the Neurological Sciences, 2008, 265, 1-2, 17

    CrossRef

  58. 58
    Stephen G Waxman, Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status, Nature Clinical Practice Neurology, 2008, 4, 3, 159

    CrossRef

  59. 59
    Alastair Compston, Alasdair Coles, Multiple sclerosis, The Lancet, 2008, 372, 9648, 1502

    CrossRef

  60. 60
    Joel A. Black, Stephen G. Waxman, Phenytoin protects central axons in experimental autoimmune encephalomyelitis, Journal of the Neurological Sciences, 2008, 274, 1-2, 57

    CrossRef

  61. You have free access to this content61
    D. Mahad, H. Lassmann, D. Turnbull, Review: Mitochondria and disease progression in multiple sclerosis, Neuropathology and Applied Neurobiology, 2008, 34, 6
  62. 62
    Raju Kapoor, Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine, Journal of the Neurological Sciences, 2008, 274, 1-2, 54

    CrossRef

  63. 63
    Karine Palin, Colm Cunningham, Penny Forse, V. Hugh Perry, Nick Platt, Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration, Neurobiology of Disease, 2008, 30, 1, 19

    CrossRef

  64. 64
    Claudia F. Lucchinetti, ADVANCES IN THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS, CONTINUUM: Lifelong Learning in Neurology, 2007, 13, 86

    CrossRef

  65. 65
    J.-M. Vallat, Mécanismes et prévention de la dégénérescence axonale dans les neuropathies dysimmunitaires, Revue Neurologique, 2007, 163, 5

    CrossRef

  66. 66
    Helmar C. Lehmann, Angelika Köhne, Gerd Meyer zu Hörste, Thomas Dehmel, Olivia Kiehl, Hans-Peter Hartung, Stefan Kastenbauer, Bernd C. Kieseier, Role of Nitric Oxide as Mediator of Nerve Injury in Inflammatory Neuropathies, Journal of Neuropathology and Experimental Neurology, 2007, 66, 4, 305

    CrossRef

  67. 67
    Sean J. Pittock, Claudia F. Lucchinetti, The Pathology of MS, The Neurologist, 2007, 13, 2, 45

    CrossRef

  68. 68
    Gerty Schreibelt, Jack van Horssen, Saskia van Rossum, Christine D. Dijkstra, Benjamin Drukarch, Helga E. de Vries, Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology, Brain Research Reviews, 2007, 56, 2, 322

    CrossRef

  69. 69
    Francisco A. Luque, Stephen L. Jaffe, The Neurobiology of Multiple Sclerosis, 2007,

    CrossRef

  70. 70
    Dimitrios Papadopoulos, Danielle Pham-Dinh, Richard Reynolds, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Experimental Neurology, 2006, 197, 2, 373

    CrossRef

  71. 71
    David A. Bechtold, Sandra J. Miller, Angela C. Dawson, Yue Sun, Raju Kapoor, David Berry, Kenneth J. Smith, Axonal protection achieved in a model of multiple sclerosis using lamotrigine, Journal of Neurology, 2006, 253, 12, 1542

    CrossRef

  72. 72
    Daniel J. Cuthill, Jill H. Fowler, James McCulloch, Deborah Dewar, Different patterns of axonal damage after intracerebral injection of malonate or AMPA, Experimental Neurology, 2006, 200, 2, 509

    CrossRef

  73. 73
    A. Créange, Dixièmes Journées des Maladies du Système Nerveux Périphérique Intolérance au glucose : la face cachée des neuropathies idiopathiques ?, Revue Neurologique, 2006, 162, 12, 1284

    CrossRef

  74. 74
    J.-P. Lefaucheur, D. Boërio, J.-Y. Hogrel, A. Créange, Étude de l’excitabilité nerveuse dans l’exploration des neuropathies dysimmunitaires, Revue Neurologique, 2006, 162, 17

    CrossRef

  75. 75
    Stephen G. Waxman, Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis, Trends in Molecular Medicine, 2006, 12, 5, 192

    CrossRef

  76. 76
    Valerie M. Anderson, Nick C. Fox, David H. Miller, Magnetic resonance imaging measures of brain atrophy in multiple sclerosis, Journal of Magnetic Resonance Imaging, 2006, 23, 5
  77. 77
    Alexandre I. Danilov, Ruxandra Covacu, Morten C. Moe, Iver A. Langmoen, Clas B. Johansson, Tomas Olsson, Lou Brundin, Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis, European Journal of Neuroscience, 2006, 23, 2
  78. 78
    Raju Kapoor, Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design, Current Opinion in Neurology, 2006, 19, 3, 255

    CrossRef

  79. 79
    Maria Diaz-Sanchez, Kelly Williams, Gabriele C. DeLuca, Margaret M. Esiri, Protein co-expression with axonal injury in multiple sclerosis plaques, Acta Neuropathologica, 2006, 111, 4, 289

    CrossRef

  80. 80
    Stephen L. Hauser, Jorge R. Oksenberg, The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration, Neuron, 2006, 52, 1, 61

    CrossRef

  81. 81
    A. J. Coles, A. Cox, E. Page, J. Jones, S. A. Trip, J. Deans, S. Seaman, D. H. Miller, G. Hale, H. Waldmann, D. A. Compston, The window of therapeutic opportunity in multiple sclerosis, Journal of Neurology, 2006, 253, 1, 98

    CrossRef

  82. 82
    C. Yang, W. Hader, X. Zhang, Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite, Brain Research, 2006, 1076, 1, 238

    CrossRef

  83. 83
    Fahmy Aboul-Enein, Peter Weiser, Romana Höftberger, Hans Lassmann, Monika Bradl, Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis, Acta Neuropathologica, 2006, 111, 6, 539

    CrossRef

  84. 84
    McAlpine's Multiple Sclerosis, 2006,

    CrossRef

  85. 85
    Olga Ciccarelli, Ahmed Toosy, Neurological Rehabilitation of Multiple Sclerosis, 2006,

    CrossRef

  86. 86
    Gareth Pryce, Janet K. O'Neill, J. Ludovic Croxford, Sandra Amor, Deborah J. Hankey, Emma East, Gavin Giovannoni, David Baker, Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis, Journal of Neuroimmunology, 2005, 165, 1-2, 41

    CrossRef

  87. 87
    Sandra Amor, Paul A. Smith, Bert 't Hart, David Baker, Biozzi mice: Of mice and human neurological diseases, Journal of Neuroimmunology, 2005, 165, 1-2, 1

    CrossRef

  88. 88
    Samuel J. Jackson, Lara T. Diemel, Gareth Pryce, David Baker, Cannabinoids and neuroprotection in CNS inflammatory disease, Journal of the Neurological Sciences, 2005, 233, 1-2, 21

    CrossRef

  89. 89
    Wolfgang Brück, Clinical implications of neuropathological findings in multiple sclerosis, Journal of Neurology, 2005, 252, S3, iii10

    CrossRef

  90. 90
    Alexandre I. Danilov, Maja Jagodic, N. Peter Wiklund, Tomas Olsson, Lou Brundin, Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE, Nitric Oxide, 2005, 13, 3, 188

    CrossRef

  91. 91
    Peter K. Stys, General mechanisms of axonal damage and its prevention, Journal of the Neurological Sciences, 2005, 233, 1-2, 3

    CrossRef

  92. 92
    Jerome J.A. Hendriks, Charlotte E. Teunissen, Helga E. de Vries, Christine D. Dijkstra, Macrophages and neurodegeneration, Brain Research Reviews, 2005, 48, 2, 185

    CrossRef

  93. 93
    H.E. Andrews, P.P. Nichols, D. Bates, D.M. Turnbull, Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis, Medical Hypotheses, 2005, 64, 4, 669

    CrossRef

  94. 94
    Orhan Aktas, New aspects regarding mechanisms of tissue damage in the course of autoimmune demyelination , Signal Transduction, 2005, 5, 5
  95. 95
    S. Anand Trip, Patricio G. Schlottmann, Stephen J. Jones, Daniel R. Altmann, David F. Garway-Heath, Alan J. Thompson, Gordon T. Plant, David H. Miller, Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis, Annals of Neurology, 2005, 58, 3
  96. 96
    David A. Bechtold, Kenneth J. Smith, Sodium-mediated axonal degeneration in inflammatory demyelinating disease, Journal of the Neurological Sciences, 2005, 233, 1-2, 27

    CrossRef

  97. 97
    Claudia F. Lucchinetti, Joseph Parisi, Wolfgang Bruck, The pathology of multiple sclerosis, Neurologic Clinics, 2005, 23, 1, 77

    CrossRef

  98. 98
    Wolfgang Brück, The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage, Journal of Neurology, 2005, 252, S5, v3

    CrossRef

  99. 99
    Lara Teare, John Zajicek, The use of cannabinoids in multiple sclerosis, Expert Opinion on Investigational Drugs, 2005, 14, 7, 859

    CrossRef

  100. 100
    C. Espejo, M. Penkowa, M. Demestre, X. Montalban, E.M. Martínez-Cá;ceres, Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis, Neuroscience, 2005, 132, 4, 1135

    CrossRef

  101. 101
    Alastair Wilkins, Alastair Compston, Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling pathways, Journal of Neurochemistry, 2005, 92, 6
  102. 102
    Kenneth J. Smith, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  103. 103
    Stephen G. Waxman, Albert C. Lo, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  104. 104
    Theodore R. Cummins, Stephen G. Waxman, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  105. 105
    Hans Lassmann, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  106. 106
    V. Hugh Perry, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  107. 107
    Peter K. Stys, Stephen G. Waxman, Multiple Sclerosis As A Neuronal Disease, 2005,

    CrossRef

  108. 108
    Nikolaos Grigoriadis, Tamir Ben-Hur, Dimitrios Karussis, Ioannis Milonas, Axonal damage in multiple sclerosis: a complex issue in a complex disease, Clinical Neurology and Neurosurgery, 2004, 106, 3, 211

    CrossRef

  109. 109
    David A. Bechtold, Raju Kapoor, Kenneth J. Smith, Axonal protection using flecainide in experimental autoimmune encephalomyelitis, Annals of Neurology, 2004, 55, 5
  110. 110
    Samuel J. Jackson, David Baker, M. Louise Cuzner, Lara T. Diemel, Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture, European Journal of Neuroscience, 2004, 20, 9
  111. 111
    Inge Huitinga, Zeynel A. Erkut, Denis van Beurden, Dick F. Swaab, Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions, Annals of Neurology, 2004, 55, 1
  112. 112
    Raija L.P Lindberg, Corline J.A De Groot, Ulrich Certa, Rivka Ravid, Francine Hoffmann, Ludwig Kappos, David Leppert, Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS, Journal of Neuroimmunology, 2004, 152, 1-2, 154

    CrossRef

  113. 113
    Ian McDonald, Multiple Sclerosis in its European Matrix: Some Aspects of History, Mechanisms and Treatment, The Canadian Journal of Neurological Sciences, 2004, 31, 01, 37

    CrossRef

  114. 114
    Alireza Minagar, Eduardo Gonzalez Toledo, J. Steven Alexander, Roger E. Kelley, Pathogenesis of Brain and Spinal Cord Atrophy in Multiple Sclerosis, Journal of Neuroimaging, 2004, 14,
  115. 115
    Alastair Compston, The pathogenesis and basis for treatment in multiple sclerosis, Clinical Neurology and Neurosurgery, 2004, 106, 3, 246

    CrossRef

  116. 116
    Monica Morini, Luca Roccatagliata, Raffaella Dell'Eva, Enrico Pedemonte, Roberto Furlan, Simona Minghelli, Debora Giunti, Ulrich Pfeffer, Monica Marchese, Douglas Noonan, Gianluigi Mancardi, Adriana Albini, Antonio Uccelli, α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis, Journal of Neuroimmunology, 2004, 148, 1-2, 146

    CrossRef

  117. 117
    Kottil W. Rammohan, Axonal injury in multiple sclerosis, Current Neurology and Neuroscience Reports, 2003, 3, 3, 231

    CrossRef

  118. 118
    C Bjartmar, J.R Wujek, B.D Trapp, Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease, Journal of the Neurological Sciences, 2003, 206, 2, 165

    CrossRef

  119. 119
    Hans Lassmann, Hypoxia-like tissue injury as a component of multiple sclerosis lesions, Journal of the Neurological Sciences, 2003, 206, 2, 187

    CrossRef

  120. 120
    Ralf Gold, Marinos C Dalakas, Klaus V Toyka, Immunotherapy in autoimmune neuromuscular disorders, The Lancet Neurology, 2003, 2, 1, 22

    CrossRef

  121. 121
    Jill H. Fowler, Eileen McCracken, Deborah Dewar, James McCulloch, Intracerebral injection of AMPA causes axonal damage in vivo, Brain Research, 2003, 991, 1-2, 104

    CrossRef

  122. 122
    Harald Neumann, Molecular mechanisms of axonal damage in inflammatory central nervous system diseases, Current Opinion in Neurology, 2003, 16, 3, 267

    CrossRef

  123. 123
    Alexandre I. Danilov, Magnus Andersson, Nasrin Bavand, N.Peter Wiklund, Tomas Olsson, Lou Brundin, Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis, Journal of Neuroimmunology, 2003, 136, 1-2, 112

    CrossRef

  124. 124
    Oliver Neuhaus, Bernd C Kieseier, Juan J Archelos, Hans-Peter Hartung, Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis, Trends in Pharmacological Sciences, 2003, 24, 11, 564

    CrossRef

  125. 125
    Satoshi Kuwabara, Hugh Bostock, Kazue Ogawara, Jia-Ying Sung, Kazuaki Kanai, Masahiro Mori, Takamichi Hattori, David Burke, The refractory period of transmission is impaired in axonal Guillain–Barré syndrome, Muscle & Nerve, 2003, 28, 6
  126. 126
    Heike Siebert, Wolfgang Brück, The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice, Brain Research, 2003, 960, 1-2, 152

    CrossRef

  127. 127
    Kenneth J. Smith, W. Ian McDonald, Multiple Sclerosis 2, 2003,

    CrossRef

  128. 128
    Peter Rieckmann, Mathias Mäurer, Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis, Current Opinion in Neurology, 2002, 15, 3, 361

    CrossRef

  129. 129
    Maria K. Storch, Robert Weissert, Andreas Stefferl, Robert Birnbacher, Erik Wallström, Ingrid Dahlman, Claes Göran Ostensson, Christopher Linington, Tomas Olsson, Hans Lassmann, MHC Gene Related Effects on Microglia and Macrophages in Experimental Autoimmune Encephalomyelitis Determine the Extent of Axonal Injury, Brain Pathology, 2002, 12, 3
  130. 130
    Alastair Compston, Alasdair Coles, Multiple sclerosis, The Lancet, 2002, 359, 9313, 1221

    CrossRef

  131. 131
    Christian Krarup, Nerve conduction studies in selected peripheral nerve disorders, Current Opinion in Neurology, 2002, 15, 5, 579

    CrossRef

  132. 132
    Albert C. Lo, Joel A. Black, Stephen G. Waxman, Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis, NeuroReport, 2002, 13, 15, 1909

    CrossRef

  133. 133
    Kenneth J Smith, Hans Lassmann, The role of nitric oxide in multiple sclerosis, The Lancet Neurology, 2002, 1, 4, 232

    CrossRef

  134. 134
    Kenneth J. Smith, Susan M. Hall, Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding, Current Opinion in Neurology, 2001, 14, 3, 289

    CrossRef

  135. 135
    Nur Yuceyar, Dilek Taşkiran, Ayşe Sağduyu, Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients, Clinical Neurology and Neurosurgery, 2001, 103, 4, 206

    CrossRef